SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-12-022840
Filing Date
2012-03-30
Accepted
2012-03-30 16:00:00
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a12-2664_110k.htm 10-K 2833526
2 EX-21 a12-2664_1ex21.htm EX-21 1816
3 EX-23.1 a12-2664_1ex23d1.htm EX-23.1 3975
4 EX-23.2 a12-2664_1ex23d2.htm EX-23.2 3827
5 EX-31.1 a12-2664_1ex31d1.htm EX-31.1 13997
6 EX-31.2 a12-2664_1ex31d2.htm EX-31.2 14005
7 EX-32.1 a12-2664_1ex32d1.htm EX-32.1 4679
8 EX-32.2 a12-2664_1ex32d2.htm EX-32.2 4725
  Complete submission text file 0001104659-12-022840.txt   7423799

Data Files

Seq Description Document Type Size
9 EX-101.INS cycc-20111231.xml EX-101.INS 953805
10 EX-101.SCH cycc-20111231.xsd EX-101.SCH 23365
11 EX-101.CAL cycc-20111231_cal.xml EX-101.CAL 79042
12 EX-101.DEF cycc-20111231_def.xml EX-101.DEF 110638
13 EX-101.LAB cycc-20111231_lab.xml EX-101.LAB 363381
14 EX-101.PRE cycc-20111231_pre.xml EX-101.PRE 158111
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 12729084
SIC: 2834 Pharmaceutical Preparations